PBEvsIHIETF Comparison
Invesco Dynamic Biotechnology & Genome ETF (PBE) belongs to the BioTech & Genomics segment. iShares U.S. Medical Devices ETF (IHI) is part of the US Health Care segment. Both ETFs have the same top 3 sector exposures: and Health Care. PBE is more expensive with a Total Expense Ratio (TER) of 0.58%, versus 0.38% for IHI. PBE is down -2.66% year-to-date (YTD) with -$2M in YTD flows. IHI performs worse with -14.99% YTD performance, and -$236M in YTD flows. Run a side-by-side ETF comparison of PBE and IHI below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
PBE vs IHI performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | PBE IHI | +4.27%-2.40% | -3.98%-13.04% | -2.66%-14.99% | +32.11%-10.54% | +28.24%-6.36% | +3.38%-10.49% |
| Flows | PBE IHI | +$2M+$68M | -$6M-$197M | -$2M-$236M | -$30M-$893M | -$58M-$2.87B | -$43M-$4.89B |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | PBE IHI | +19.57%+18.24% | +19.83%+15.91% | +20.15%+16.75% | +22.54%+18.85% |
| Max drawdown | PBE IHI | -9.36%-13.90% | -11.70%-18.81% | -22.21%-22.87% | -34.74%-33.07% |
| Max drawdown duration | PBE IHI | 75d88d | 107d150d | 324d210d | 1540d1689d |
PBE | IHI | |
Last sale 4/27/2026 at 1:30 PM | $79.93 | $52.72 |
| Previous close 04/24/2026 | $79.82 | $52.81 |
| Consolidated volume 04/24/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
PBE | IHI | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
PBE | IHI | |
|---|---|---|
| Last price | $79.93 | $52.72 |
| 1D performance | +0.14% | -0.17% |
| AuM | $249.88 M | $3.23 B |
| E/R | 0.58% | 0.38% |
PBE | IHI | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | Invesco | iShares |
| Benchmark | Dynamic Biotech & Genome Intellidex Index | Dow Jones U.S. Select Medical Equipment Index |
| N° of holdings | 30 | 46 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 23, 2005 | May 1, 2006 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
